Player FM ऐप के साथ ऑफ़लाइन जाएं!
पॉडकास्ट सुनने लायक
प्रायोजित
![You Can’t Make This Up podcast artwork](https://cdn.player.fm/images/21055062/series/xUxSMTjIutrzxfGp/32.jpg 32w, https://cdn.player.fm/images/21055062/series/xUxSMTjIutrzxfGp/64.jpg 64w, https://cdn.player.fm/images/21055062/series/xUxSMTjIutrzxfGp/128.jpg 128w, https://cdn.player.fm/images/21055062/series/xUxSMTjIutrzxfGp/256.jpg 256w, https://cdn.player.fm/images/21055062/series/xUxSMTjIutrzxfGp/512.jpg 512w)
![You Can’t Make This Up podcast artwork](/static/images/64pixel.png)
#35 Veterinary pharmacovigilance part 2 – James Mount
Manage episode 463560247 series 2749727
Human and veterinary pharmacovigilance (PV) share many goals, challenges and approaches. But there are also significant differences, such as the numerous animal species that veterinary PV needs to take into account. In this two-part episode of Drug Safety Matters, James Mount, Veterinary Pharmacovigilance assessor at the Swedish Medical Products Agency, and EU elected chair of the Pharmacovigilance Working Party for veterinary medicinal products, joins the show to talk about veterinary PV practice and its differences and similarities to human PV.
In part 2, you will hear about
- differences in types of ADRs reported for animals as compared to humans,
- when humans are accidentally exposed to medicines for animals, and vice versa,
- how the many species and breeds included in veterinary PV affects the coding of ADR reports,
- breed-specific ADRs – what is safe for one breed of e.g. dog or pig, may not be appropriate for another,
- the EU Veterinary Big Data Strategy,
... and much more!
Links for further reading
- The public portal of the European Union Veterinary Pharmacovigilance Database.
- One Health – an integrated approach to the well-being of people, animals and the environment.
- A survey of veterinary professionals in Sweden, about practices and attitudes in relation to ADR reporting.
- A review of adverse events in animals and children after secondary exposure to transdermal hormone-containing medicines.
- The EMA Big Data strategy for veterinary medicines.
- Data quality framework for medicines regulation | European Medicines Agency (EMA)
- Small Animal Veterinary Surveillance Network (SAVSNET) - University of Liverpool
- VetCompass - Royal Veterinary College, RVC
- Reflection paper on the use of artificial intelligence in the lifecycle of medicines | European Medicines Agency (EMA)
- Veterinary good pharmacovigilance practices (VGVP) | European Medicines Agency (EMA)
- Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) | European Medicines Agency (EMA)
Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.
अध्यायों
1. #35 Veterinary pharmacovigilance part 2 – James Mount (00:00:00)
2. Intro (00:00:14)
3. Welcome (00:01:00)
4. Types of ADRs reported in veterinary vs human PV (00:01:18)
5. User safety – when humans are accidentally exposed to veterinary medicines (00:02:41)
6. When animals are accidentally exposed to human medicines (00:06:33)
7. Gentamicin – an illustrative example of the overlap between human and veterinary PV (00:08:46)
8. Differences in ADR reporting between the veterinary and human side (00:10:03)
9. Environmental aspects in veterinary PV (00:13:27)
10. Vet PV's diversity in stakeholders, target groups and patients (species, breeds) (00:16:18)
11. Listener question: differences in susceptibility to certain ADRs between different breeds (and species) (00:19:04)
12. Technological solutions for discovering ADRs in animals? (00:23:52)
13. Signal detection in veterinary PV practice (00:26:44)
14. The EU Veterinary Big Data Strategy (00:29:54)
15. AI in PV in the near future (00:35:44)
16. Outro (00:40:15)
52 एपिसोडस
Manage episode 463560247 series 2749727
Human and veterinary pharmacovigilance (PV) share many goals, challenges and approaches. But there are also significant differences, such as the numerous animal species that veterinary PV needs to take into account. In this two-part episode of Drug Safety Matters, James Mount, Veterinary Pharmacovigilance assessor at the Swedish Medical Products Agency, and EU elected chair of the Pharmacovigilance Working Party for veterinary medicinal products, joins the show to talk about veterinary PV practice and its differences and similarities to human PV.
In part 2, you will hear about
- differences in types of ADRs reported for animals as compared to humans,
- when humans are accidentally exposed to medicines for animals, and vice versa,
- how the many species and breeds included in veterinary PV affects the coding of ADR reports,
- breed-specific ADRs – what is safe for one breed of e.g. dog or pig, may not be appropriate for another,
- the EU Veterinary Big Data Strategy,
... and much more!
Links for further reading
- The public portal of the European Union Veterinary Pharmacovigilance Database.
- One Health – an integrated approach to the well-being of people, animals and the environment.
- A survey of veterinary professionals in Sweden, about practices and attitudes in relation to ADR reporting.
- A review of adverse events in animals and children after secondary exposure to transdermal hormone-containing medicines.
- The EMA Big Data strategy for veterinary medicines.
- Data quality framework for medicines regulation | European Medicines Agency (EMA)
- Small Animal Veterinary Surveillance Network (SAVSNET) - University of Liverpool
- VetCompass - Royal Veterinary College, RVC
- Reflection paper on the use of artificial intelligence in the lifecycle of medicines | European Medicines Agency (EMA)
- Veterinary good pharmacovigilance practices (VGVP) | European Medicines Agency (EMA)
- Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) | European Medicines Agency (EMA)
Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.
अध्यायों
1. #35 Veterinary pharmacovigilance part 2 – James Mount (00:00:00)
2. Intro (00:00:14)
3. Welcome (00:01:00)
4. Types of ADRs reported in veterinary vs human PV (00:01:18)
5. User safety – when humans are accidentally exposed to veterinary medicines (00:02:41)
6. When animals are accidentally exposed to human medicines (00:06:33)
7. Gentamicin – an illustrative example of the overlap between human and veterinary PV (00:08:46)
8. Differences in ADR reporting between the veterinary and human side (00:10:03)
9. Environmental aspects in veterinary PV (00:13:27)
10. Vet PV's diversity in stakeholders, target groups and patients (species, breeds) (00:16:18)
11. Listener question: differences in susceptibility to certain ADRs between different breeds (and species) (00:19:04)
12. Technological solutions for discovering ADRs in animals? (00:23:52)
13. Signal detection in veterinary PV practice (00:26:44)
14. The EU Veterinary Big Data Strategy (00:29:54)
15. AI in PV in the near future (00:35:44)
16. Outro (00:40:15)
52 एपिसोडस
सभी एपिसोड
×![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #35 Veterinary pharmacovigilance part 2 – James Mount 41:42
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #34 Veterinary pharmacovigilance, Part I – James Mount 47:21
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias 38:43
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #32 Pharmacovigilance in older adults – Giovanni Furlan 47:51
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori 42:45
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects 25:02
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance 30:18
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #30 Preventing and reporting medication errors – Rabat CC & UMC 33:58
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #29 When medicines change our behaviour – Michele Fusaroli 30:30
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #28 Catching black swans – François Montastruc 27:21
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #27 When drugs damage the liver – Rita Baião 28:30
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #26 What's trending in pharmacovigilance? – Angela Caro 28:06
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #25 A week in the name of medicines safety – part 2 33:13
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #24 A week in the name of medicines safety – part 1 27:09
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 Uppsala Reports Long Reads – The colour of signals 33:59
प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।